SYNERGETICS USA INC 4

Accession 0001140361-15-037687

CIK 0000836429operating

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 2:22 PM ET

Size

22.6 KB

Accession

0001140361-15-037687

Form 4

Period: 2015-10-15

Director

Transactions

Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $2.95Exp: 2017-12-07→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $4.43Exp: 2020-12-16→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $4.52Exp: 2022-12-14→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $3.70Exp: 2024-12-12→ Common Stock (10,000 underlying)
Disposition from Tender
Common Stock
2015-10-15−44,243→ 0 total
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $1.37Exp: 2019-12-17→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $3.77Exp: 2016-11-30→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $3.46Exp: 2023-12-13→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock option (right to buy)
2015-10-15−10,000→ 0 total
Exercise: $6.21Exp: 2021-12-14→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]Shares tendered for an offer price of $6.50 per share in cash (the "Cash Consideration") plus one non-transferable contractual contingent value right per share (each, a "CVR"), which represents the right to receive up to two contingent payments, if any, of up to $1.00 in the aggregate, net to the holder in cash, upon the achievement of certain specified milestones within an agreed upon time period (less any applicable withholding taxes and without interest), pursuant to the tender offer consummated on September 16, 2015 according to the terms of the Agreement and Plan of Merger (the "Merger" Agreement"), dated as of September 1, 2015, by and among Valeant Pharmaceuticals International, Blue Subsidiary Corp. and Synergetics USA, Inc.
[F2]The Form 4 reporting the award of the stock option on November 30, 2006 reported an exercise price of $3.89 in error.
[F3]Pursuant to the terms of the Merger Agreement, on October 15, 2015, each option outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) was canceled in exchange for (i) a cash payment equal to the product of (A) the number of shares underlying the option and (B) the difference between the Cash Consideration and the exercise price of the option; and (ii) one CVR for each share underlying the option, in each case without interest and subject to any applicable tax withholding.

Documents

1 file

SYNERGETICS USA INC

CIK 0000836429

Entity typeoperating